1 min read

Study Finds NuLiv Science Ingredient, Verbasnol™, Helps Reduce Acne Severity and Improves Overall Skin Quality 

We are excited to announce the release of a study examining the efficacy and safety of Verbasnol™ (Rehmannia glutinosa Libosch leaf-based extract (RGLE)) examining various aspects of skin health in females.

Published in Clinical, Cosmetic and Investigational Dermatology (Study Link) – a Dovepress medical online journal, the paper demonstrates that Verbasnol™, NuLiv Science’s plant-based skincare ingredient, may be effective in alleviating acne severity. Remarkably, 80% of participants experienced improvements in their acne condition during the course of the study. 

Spanning over a two-month period, the study focused on adult women with poor Global Acne Grading Systems (“GAGS”) scores, a widely accepted metric in dermatology for evaluating acne severity. 

Each participant was administered either a capsule of Versbasnol™ or a placebo for 56 days.  Results revealed significant improvements in GAGS scores by day 28, with further noteworthy enhancements observed by day 56, including improvements in skin characteristics such as complexion, luminosity and overall quality.

This clinical evidence, corroborated by standardized GAGS scores, makes a compelling case for incorporating Verbasnol™ into skincare formulations of skincare brands.  In addition, these findings present a unique opportunity for skincare brands to leverage the research data in order to strengthen and differentiate their products in the market.

About NuLiv Science

NuLiv Science, a Certified B-Corp, is a plant-based nutraceutical ingredients company that leverages the heritage of Traditional Chinese Medicine (TCM) to produce branded specialty ingredients.  Partnering with academia for innovative and scientifically-based methods, NuLiv Science provides herbal-based wellness ingredients that enable people to lead healthier lives.  

Verbasnol™ and Skin Health

To learn more about Verbasnol™ and its effects on skin health click here.